Compare Tyson Foods, Inc. (TSN) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tyson Foods, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Tyson Foods, Inc. trades at $57.25 (market cap $20.42B), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: Tyson Foods, Inc. pays a 3.52% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Tyson Foods, Inc. nearer its low. Which is the better fit depends on your goals.
| TSN | XBI | |
|---|---|---|
Market Cap | $20.42B | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $68.75 | $164.28 |
52-Week Low | $50.72 | $85.16 |
Enterprise Value | $28.01B | — |
Dividend Yield | 3.52% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
